Protalix BioTherapeutics Ratios (2010-2025) | PLX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Profitability
Gross Margin (Quarter)	57.91%	26.36%	69.28%	63.18%	62.49%	53.31%	50.12%	72.18%	67.82%	82.47%	52.70%	15.54%	30.58%	29.82%	53.37%	78.67%	19.11%	62.51%	53.37%	49.36%
EBT Margin (Quarter)	-51.78%	-176.89%	-35.63%	-77.37%	-14.21%	-60.94%	-25.15%	-37.25%	-30.62%	56.01%	-16.62%	-210.31%	-126.28%	-16.86%	21.40%	65.12%	-36.90%	4.22%	12.54%	-2.16%
EBIT Margin (Quarter)	-32.73%	-142.62%	-15.64%	-66.74%	-11.63%	-63.11%	-22.03%	-28.95%	-25.65%	58.22%	-18.24%	-136.14%	-129.56%	-18.01%	22.22%	22.86%	-40.99%	7.48%	11.94%	-3.68%
EBITDA Margin (Quarter)	-32.73%	-142.62%	-15.64%	-66.74%	-11.63%	-63.11%	-22.03%	-28.95%	-25.65%	58.22%	-18.24%	-136.14%	-129.56%	-15.64%	24.05%	24.69%	-40.99%	9.78%	14.02%	0.56%
Operating Margin (Quarter)	-32.73%	-142.62%	-15.64%	-66.74%	-11.63%	-63.11%	-22.03%	-28.95%	-25.65%	58.22%	-18.24%	-136.14%	-129.56%	-18.01%	22.22%	22.86%	-40.99%	7.48%	11.94%	-3.68%
Net Margin (Quarter)	-51.78%	-176.89%	-35.63%	-77.37%	-14.21%	-60.94%	-25.15%	-37.25%	-32.66%	55.14%	-17.90%	-177.18%	-122.60%	-16.35%	18.02%	61.91%	-35.79%	1.05%	13.52%	-12.08%
FCF Margin (Quarter)	-90.28%	97.01%	-18.45%	-48.78%	-37.66%	-82.35%	-67.25%	-32.77%	-34.67%	13.82%	-70.90%	31.90%	107.84%	-31.42%	22.37%	25.22%	-53.04%	-36.17%	-23.70%	31.75%
Efficiency
Inventory Average (Quarter)	13.50M	13.78M	14.19M	16.34M	17.27M	16.55M	15.53M	15.68M	18.55M	19.97M	20.61M	20.31M	20.70M	21.53M	18.96M	19.22M	20.37M	20.32M	21.19M	23.49M
Assets Average (Quarter)	85.36M	105.50M	95.84M	78.57M	71.03M	64.52M	58.67M	56.25M	61.17M	77.49M	87.99M	86.00M	87.13M	90.68M	76.55M	67.49M	73.65M	76.19M	80.38M	82.31M
Equity Average (Quarter)	-6.27M	9.17M	2.03M	-2.91M	-6.76M	-8.69M	-10.70M	-11.08M	-4.82M	20.00M	38.62M	35.91M	31.68M	29.18M	30.51M	37.82M	44.21M	47.56M	51.41M	50.57M
Invested Capital (Quarter)	69.88M	60.20M	3.45M	-6.04M	-7.49M	-9.89M	-11.51M	-10.64M	1.01M	39.00M	58.44M	53.82M	50.21M	49.00M	32.44M	43.21M	45.21M	49.90M	52.91M	48.23M
Asset Utilization Ratio (Quarter)	0.62	0.46	0.51	0.49	0.61	0.70	0.81	0.85	0.67	0.87	0.72	0.76	0.68	0.42	0.60	0.79	0.81	0.81	0.77	0.64
Leverage & Solvency
Interest Coverage Ratio (Quarter)	-1.72	-4.16	-0.78	-6.28	-3.03	-8.87	-4.89	-3.84	-3.79	15.65	-4.10	-18.44	-12.45	-6.40	15.35	101.56	-690.83
Debt to Equity (Quarter)	3.82	14.67	15.21								0.53	0.60	0.69	0.71
Debt Ratio (Quarter)	0.54	0.52	0.04								0.23	0.24	0.23	0.22
Equity Ratio (Quarter)	0.14	0.04	0.00	-0.08	-0.11	-0.16	-0.20	-0.19	0.02	0.44	0.44	0.40	0.33	0.31	0.53	0.59	0.61	0.64	0.64	0.59
Times Interest Earned (Quarter)	-1.72	-4.16	-0.78	-6.28	-3.03	-8.87	-4.89	-3.84	-3.79	15.65	-4.10	-18.44	-12.45	-6.40	15.35	101.56	-690.83
Valuation
Enterprise Value (Quarter)	-70.43M	-76.94M	-48.66M	-38.98M	-32.92M	-28.57M	-20.81M	-22.18M	-33.04M	-48.18M	-40.98M	-44.56M	-48.49M	-45.03M	-27.41M	-15.07M	-34.74M	-33.40M	-29.37M	-16.30M
Return Ratios
Return on Sales (Quarter)	-0.52%	-1.77%	-0.36%	-0.77%	-0.14%	-0.61%	-0.25%	-0.37%	-0.33%	0.55%	-0.18%	-1.77%	-1.23%	-0.16%	0.18%	0.62%	-0.36%	0.01%	0.14%	-0.12%
Return on Capital Employed (Quarter)	-1.26%	-1.36%	-0.22%	-0.45%	-0.52%	-0.45%	-0.67%	-0.55%	-0.46%	0.23%	0.30%	0.04%	-0.02%	-0.72%	-0.34%	0.02%	0.03%	0.10%	0.06%	-0.02%
Return on Invested Capital (Quarter)												0.02%	-0.01%	-0.42%	-0.38%	0.02%	0.03%	0.10%	0.06%	-0.05%
Return on Assets (Quarter)	-0.17%	-0.20%	-0.22%	-0.36%	-0.35%	-0.29%	-0.30%	-0.26%	-0.25%	0.12%	0.13%	-0.05%	-0.07%	-0.30%	-0.29%	0.11%	0.12%	0.15%	0.13%	-0.03%
Return on Equity (Quarter)	2.28%	-2.34%	-10.46%	9.66%	3.63%	2.13%	1.66%	1.30%	3.16%	0.47%	0.29%	-0.12%	-0.18%	-0.93%	-0.73%	0.20%	0.20%	0.23%	0.20%	-0.04%

Research Tools

Protalix BioTherapeutics Ratios (2010-2025) | PLX

Create an account

Sign In

Reset Password